Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07156253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors
Trial Details
NCT Number NCT07156253
Lead Sponsor Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Conditions
(from sponsor)		 Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA 1 /2 and / or HRD, Advanced Solid Tumors
Related terms Breast Neoplasms, Kenny-Caffey syndrome, Type 1, Neoplasm Metastasis, Ovarian Neoplasms
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov